SCHEMBL8357372

SCHEMBL8357372

Bc1ccc(O)c(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16302570 0.79 — —
Water SCHEMBL27823593 0.77 CA3 (0.54) —
SCHEMBL12667819 0.75 — —
SCHEMBL9269096 0.75 — —
SCHEMBL29630314 0.72 — —
SCHEMBL857363 0.72 ESR1 (0.68) —
SCHEMBL30635318 0.72 ESR1 (0.68) —
SCHEMBL185204 0.72 — —
SCHEMBL29619760 0.72 — —
SCHEMBL2453961 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116731315-B Boron-containing phthalonitrile resin and preparation method and application thereof 中国科学院化学研究所 2024-06-21 — — CN claimed
CN-116731315-A Boron-containing phthalonitrile resin and preparation method and application thereof 中国科学院化学研究所 2023-09-12 — — CN claimed
CN-116731315-B Boron-containing phthalonitrile resin and preparation method and application thereof 中国科学院化学研究所 2024-06-21 — — CN disclosed
CN-116731315-A Boron-containing phthalonitrile resin and preparation method and application thereof 中国科学院化学研究所 2023-09-12 — — CN disclosed
EP-3929196-B1 PHARMACEUTICAL COMPOSITION OF A NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF FUJIFILM CORP (JP) 2023-08-23 — — EP disclosed
EP-3050878-B1 NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF FUJIFILM CORP (JP) 2021-10-27 — — EP disclosed
WO-2015110263-A1 CARBAZOLE AND CARBOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH AMYLOID OR AMYOLID-LIKE PROTEINS AC IMMUNE SA (CH) 2015-07-30 — — WO disclosed
WO-2015074737-A1 MESOGENIC MEDIA AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2015-05-28 — — WO disclosed
EP-2155722-B1 POLYCYCLIC INDAZOLE DERIVATIVES AND THEIR USE AS ERK INHIBITORS FOR THE TREATMENT OF CANCER MERCK SHARP & DOHME (US) 2013-08-14 — — EP disclosed
EP-2399585-A1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase Infinity Pharmaceuticals, Inc. (US) 2011-12-28 — — EP disclosed
WO-2011040373-A1 LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT チッソ株式会社 (JP) 2011-04-07 — — WO disclosed
EP-1900792-B1 Fluorine phenyl compounds for liquid crystalline mixtures MERCK PATENT GMBH (DE) 2010-08-04 — — EP disclosed
EP-1174412-B1 POLYMERIZABLE COMPOSITION SHOWING LIQUID-CRYSTAL PHASE AND OPTICALLY ANISOTROPIC FILM PREPARED FROM SAID COMPOSITION DAINIPPON INK & CHEMICALS (JP) 2008-12-17 — — EP disclosed
EP-1780192-A1 METHOD FOR PRODUCING DIBROMOFLUOROBENZENE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-05-02 — — EP disclosed
WO-2003053915-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2003-07-03 — — WO disclosed
Send feedback